Preconference Skills Course
.jpg "Priya Gopalan, MD, FACLP photo")
Priya Gopalan, MD, FACLP
Assistant Professor of Psychiatry
University of Pittsburgh Medical Center; Western Psychiatric Hospital
Pittsburgh, Pennsylvania
.jpg "Nancy Byatt, DO FACLP photo")
Nancy Byatt, DO FACLP
Associate Professor of Psychiatry, Ob/Gyn & Population & Quantitative Health Sciences
UMass Medical School
Worcester, Massachusetts
Neeta Shenai, M.D.
Assistant Professor of Psychiatry
University of Pittsburgh Medical Center
Pittsburgh, PA
Elizabeth Albertini, MD, FAPA
Asst Professor
Icahn School of Medicine at Mount Sinai Hospital
New York, NY
Leena Mittal, MD, FACLP
Director, Division of Women's Mental Health
Brigham and Women's Hospital
Boston, MA
Marra Ackerman, MD
Director of Psychiatry FGP, Medical Student and House Staff Mental Health, and Women's Mental Health
NYU Langone Health
New York, NY
.jpg "Guitelle St. Victor, MD, FACLP, FAPA photo")
Guitelle St. Victor, MD, FACLP, FAPA
Attending Physician
Nassau University Medical Center
East Meadow, New York
This pre-conference course will focus on women's mental health as it pertains to the general consultation psychiatrist. Providing important updates in perinatal psychiatry, we will broadly discuss the management of mood disorders and other comorbid psychiatric conditions, from preconception to the postpartum period. Utilizing adult learning principles, the latest evidence for pharmacotherapy will be covered, including an up-to-date review of antidepressant, antipsychotic, and mood stabilizer use in pregnancy, in addition to the cutting-edge treatments recently approved by the Food and Drug Administration. We will present brief, easily digestible talks to provide an overview of high-impact topics in perinatal health that will directly inform clinical practice for CL psychiatrists. Using an interactive, case-based format, an overview of perinatal depression, anxiety, bipolar disorder, and substance use disorders will be presented in additions to discussions centered on the newly-approved medication brexanolone, health care disparities, new modalities of treatment, and shifting paradigms in the field. Each section will use a case as an anchor and utilize pair-and-share, choral response, and other interactive tools for the most effective teaching. Attendees will leave with an appreciation for future directions of the field, an ability to apply knowledge learned to their pregnant/postpartum mothers, and comfort in discussing proactive management of perinatal mental health with their female patients.
- Describe changes in screening recommendations and population-based health as it pertains in perinatal mood and anxiety disorders
- Review the latest studies on selective serotonin uptake inhibitors, serotonin norepinephrine reuptake inhibitors in pregnancy, including medications released in the last 5 years
- Appreciate the risks associated with untreated mood disorders and anxiety in pregnancy
- Describe fundamental management principles in perinatal addiction
- Practice a risk-benefit discussion in pregnancy for the use of common classes of medications utilizing recent studies
- Identify complications of posttraumatic stress disorder (PTSD)
- Recognize novel treatment approaches in postpartum depression care and evaluate studies on brexanolone